🏛️ Verified NIH Record • Updated 2026-07-08
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes (NCT07203768)
Unmasking Polycythemia Vera in Long-Standing Essential Thrombocythemia: A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
🩺 Plain-English Summary (8th-Grade Level)
International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).
Who can join: Review the eligibility criteria below.
Location: Mayo Clinic — Rochester, Minnesota
Age range: 18 Years to 100 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (24 Sites)
- Mayo Clinic — Rochester, Minnesota
- University Hospital Halle — Halle,
- Hannover Medical School — Hanover,
- University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center — Minden,
- Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo — Pavia, Lombardy
- Divisione Ematologia, Ospedale San Bortolo — Vicenza, Veneto
- A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia — Alessandria,
- ASST Papa Giovanni XXIII, SC Ematologia — Bergamo,
- Policlinico S. Orsola - Malpighi — Bologna,
- ASST-Spedali Civili — Brescia,
- AOU Careggi, Divisione di Ematologia — Florence,
- ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia — Milan,
- Fondazione IRCCS Cà Grande - Op. Maggiore Policlinico — Milan,
- Ospedale San Raffaele — Milan,
- ASST MONZA Ospedale San Gerardo Clinica Ematologica — Monza,
- Azienda Ospedaliera Universitaria Federico II di Napoli Divisione di Ematologia e Trapianti del Midollo — Naples,
- Azienda Ospedaliero Universitaria Maggiore della Carità di Novara SCDU Ematologia — Novara,
- Presidio Ospedaliero di Pescara — Pescara,
- Fondazione Policlinico Universitario Gemelli — Roma,
- Umberto I Policlinico — Roma,
- Azienda Ospedaliera Universitaria Integrata - Ospedale Borgo Roma, Unità di Ematologia — Verona,
- IDIBAPS, Hospital clinic — Barcelona,
- 12 Octubre University Hospital — Madrid,
- Guy's and St. Thomas' NHS Foundation Trust — London,
📞 Contact the Study Coordinator
Phone: +39 0352675134
Email: tbarbui@fondazionefrom.it
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Polycythemia Vera
- A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera — Mobile, Alabama
- Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera — Covington, Louisiana
- KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera — Birmingham, Alabama
- Study to Assess SLN124 in Patients With Polycythemia Vera — Hammond, Louisiana
- A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV — Jacksonville, Florida
Explore by condition: All Polycythemia Vera clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.